Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.2740
+0.0020 (0.74%)
Last updated: Jan 9, 2026, 8:05 AM CET
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €28.79 million as of January 9, 2026. Its market cap has increased by 190.66% in one year.
Market Cap
28.79M
Enterprise Value
28.34M
Revenue
75.52K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.27
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 28.79M, an increase of 1.05%. That is a compound annual growth rate of 0.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 28.79M | -11.61% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |